Back to Market Feed

SAXAGLIPTIN HCL 2.5 MG TABLET

saxagliptin
$1.2833per EA

Strength

2.5 mg/1

NDC

00378470593

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205980

On Market Since

8/4/2023

Pharmacological Classes

Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors

Price History

1W

0.0%

1M

-15.4%

3M

-42.8%

6M

-55.5%

1Y

-74.5%

3Y

N/A

5Y

N/A

All

-78.9%

Generic Alternatives

1 alternative • Same active ingredient

SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
00378470577•Mylan Pharmaceuticals Inc.
$1.2833

Related Drugs

Same classification

SAXAGLIPTIN HCL 5 MG TABLET
Generic
65862082630•Aurobindo Pharma Limited
$1.1692
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
65862082690•Aurobindo Pharma Limited
$1.1692
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
68462072730•Glenmark Pharmaceuticals Inc., USA
$1.1692
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
68462072790•Glenmark Pharmaceuticals Inc., USA
$1.1692
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
65862082530•Aurobindo Pharma Limited
$1.2833
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
65862082590•Aurobindo Pharma Limited
$1.2833
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
68462072630•Glenmark Pharmaceuticals Inc., USA
$1.2833
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
68462072690•Glenmark Pharmaceuticals Inc., USA
$1.2833
per EA
ALOGLIPTIN-METFORMIN 12.5-500
Generic
45802016972•Padagis Israel Pharmaceuticals Ltd
$2.1623
per EA
ALOGLIPTIN-METFORMIN 12.5-1000
Generic
45802021172•Padagis Israel Pharmaceuticals Ltd
$2.5444
per EA